Articles From: Domain.com Partners with Directi at ICANN 50 to Empower Small Businesses Globally to Retrospective Analysis of Overall Survival Adjusting for Patient Crossover in Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Presented at EHA


Domain.com and Directi, part of Endurance International Group (NASDAQ: EIGI), and global leaders in domain names , today announce a partnership kicking off at ICANN 50 to empower global small businesses with integrated, in-language tools to simplify creating a successful web presence.
Sign-up for Domain.com Partners with Directi at ICANN 50 to Empower Small Businesses Globally investment picks
LAS VEGAS , June 16, 2014 /PRNewswire/ -- International Game Technology (NYSE:IGT) , a global leader in compelling casino gaming entertainment, today issued the following statement: "IGT regularly considers, and on occasion explores, a broad range of strategic alternatives, including but not limited to business combinations, changes to our capital structure and adjustments to our portfolio of businesses, with the goal of maximizing shareholder value.
Sign-up for International Game Technology Issues Statement investment picks
OriginOil Inc. (OTC/QB: OOIL ), developer of Electro Water Separation™ ( EWS ), the high-speed, chemical-free process to clean up large quantities of water, and TriSep Corporation , designer and manufacturer of water treatment membranes, announced today that OriginOil’s EWS, combined with TriSep’s i Sep™ ultrafiltration (UF) membranes, effectively removes nearly all oil, turbidity, and bacteria, providing a full solution for drillers to efficiently recycle water flowing back from fracking and production.
Sign-up for OriginOil Technology Breakthrough Greatly Enhances Membrane Filtration, Enabling Highly Efficient Frack Water Recycling investment picks
UBTech Booth #401 — Sonic Foundry, Inc. (NASDAQ: SOFO), the trusted leader for video creation and management solutions , will unveil its new video portal, Mediasite Showcase, at UBTech 2014 this week in Las Vegas, Nev.
Sign-up for Sonic Foundry Debuts Mediasite Showcase at UBTech 2014 investment picks
Oshkosh Defense , a division of Oshkosh Corporation (NYSE: OSK), will unveil its new MRAP All-Terrain Vehicle ( M-ATV ) variants to military leaders and dignitaries from around the world at Eurosatory 2014 in Paris, starting today through June 20.
Sign-up for Oshkosh Defense Showcases New Variants of MRAP All-Terrain Vehicles at Eurosatory 2014 investment picks
HAIFA, Israel, June 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc .
Sign-up for Pluristem Receives Patent in India for Cell Therapy Production Methods and Compositions investment picks
New variant will reduce cost, increase warfighter survivability PARIS , June 16, 2014 /PRNewswire/ -- Raytheon Company (NYSE: RTN) and Thales have signed a 27-month development and five-year production agreement in support of future improvements of Raytheon's tube-launched, optically-tracked, wireless-guided (TOW) weapon system.
Sign-up for Raytheon, Thales team to upgrade TOW missile investment picks
Tests further validate surface-launched AMRAAM's role in ground-based air defense PARIS , June 16, 2014 /PRNewswire/ -- The Royal Norwegian Air Force (RNoAF) successfully fired four Raytheon Company (NYSE: RTN) Advanced Medium Range Air-to-Air Missiles (AMRAAM) from a National Advanced Surface-to-Air Missile System (NASAMS) .
Sign-up for Norway goes four-for-four with Raytheon's NASAMS investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1123841&ProfileId=051205&sourceType=1 ABERDEENSHIRE, UNITED KINGDOM --
Sign-up for Xcite Energy Limited: US$140 Million Raised Through Issue of Senior Secured Bond and Issue of New Shares investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1123848&ProfileId=051205&sourceType=1 HONG KONG, CHINA --
Sign-up for NetDimensions (Holdings) Limited: Issue of Equity and Total Voting Rights investment picks
El Paso Electric Company (EPE), a Texas-based utility servicing 395,000 customers in both west Texas and southern New Mexico, is well-positioned for the new carbon standards proposed by the Environmental Protection Agency (EPA). EPE will be coal-free by 2016 and, in less than one year, has doubled its utility-scale solar portfolio, making this west Texas-based utility a national leader in solar development.
Sign-up for Texas-Based Utility Well-Positioned for New EPA Carbon Standards: Coal-Free By 2016, Largest Solar Facility Doubles Solar Portfolio investment picks
ITASCA, Ill , June 16, 2014 /PRNewswire/ -- Arthur J.
Sign-up for Arthur J. Gallagher & Co. Completes Acquisition Of Wesfarmers' Insurance Brokerage Operations investment picks
MIDDLETOWN, R.I., June 16, 2014 (GLOBE NEWSWIRE) -- KVH Industries, Inc., (Nasdaq:KVHI) is introducing TACNAV ® 3D, a highly accurate inertial navigation system designed for battlefield vehicles, today at Eurosatory 2014, an international defense and security industry trade show in Paris, France.
Sign-up for KVH Introduces TACNAV 3D Inertial Navigation System with Embedded GPS/GNSS investment picks
ANN ARBOR, Mich., June 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, will hold an investor conference call and slide presentation on Monday, June 16, 2014 beginning at 8:30 AM EDT.
Sign-up for Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT investment picks
http://media.marketwire.com/attachments/201302/123939_IRL.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1123833&ProfileId=051205&sourceType=1 BOSTON, MA --
Sign-up for The New Ireland Fund, Inc. Announces Managed Distribution Policy and Results of Annual Meeting investment picks
Veristat, a full service Contract Research Organization, announced today that Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a Preferred Provider agreement with Veristat.
Sign-up for Veristat and Karyopharm Therapeutics Inc. Enter into Preferred Provider Agreement for Oncology and Novel Therapeutic Advancement investment picks
Access Midstream Partners, L.P. (NYSE:ACMP) (the “Partnership”) today confirmed that Williams Companies, Inc. (“Williams”) announced it had entered into an agreement to acquire all of the interests in both Access Midstream Partners, L.P. (the “Partnership”) and the Partnership’s general partner, Access Midstream Partners GP, L.L.C, currently owned by Global Infrastructure Partners II (“GIP”). If this transaction is completed, Williams will own and control the Partnership’s general partner and GIP will no longer have any ownership interest in the Partnership or its general partner.
Sign-up for Access Midstream Partners, L.P. Confirms Williams Announcement of Planned Acquisition from GIP and Proposal for Williams Partners L.P. to Merge with Access Midstream Partners, L.P. investment picks
Williams Partners L.P. (NYSE:WPZ) advised its unitholders to reference news issued today by its general partner Williams (NYSE:WMB). The partnership’s general partner, Williams, today announced a proposal for Williams Partners to merge with and into Access Midstream Partners L.P. (NYSE:ACMP). As well, Williams Partners today updated its 2014 financial guidance.
Sign-up for Williams Partners Advises Unitholders to Reference News Today From Its General Partner, Williams (NYSE:WMB); Updates 2014 Financial Guidance investment picks
--Only Rentrak Provides the Global Standard in Box Office Reporting--
Sign-up for Rentrak Announces Worldwide Box Office Results for Weekend of June 15, 2014 investment picks
Williams (NYSE:WMB) today announced that it has agreed to acquire the 50 percent general partner interest and 55.1 million limited partner units in Oklahoma City-based Access Midstream Partners L.P. (NYSE:ACMP) held by Global Infrastructure Partners II (“GIP”) for $5.995 billion in cash.
Sign-up for Williams Agrees to Acquire Global Infrastructure Partners’ GP and LP Interests in Access Midstream Partners for $5.995 Billion; Plans Higher Dividend; Proposes Subsequent Merger of Access Midstream Partners and Williams Partners investment picks
CONSISTENT 1 Trial Results Presented in Late-Breaker Poster SAN DIEGO , June 15, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today presented a scientific poster highlighting the CONSISTENT 1 trial results at the 74th Scientific Sessions of the American Diabetes Association in San Francisco .
Sign-up for Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions investment picks
Limelight Networks (Nasdaq:LLNW), a global leader in digital content delivery, today announced that it has received an unsolicited offer to purchase the company from an entity that management believes is a non-credible source.
Sign-up for Limelight Network Receives Unsolicited Offer to Purchase from Questionable Source investment picks
Oshkosh Defense , a division of Oshkosh Corporation (NYSE: OSK), will participate in daily live demonstrations at Eurosatory 2014 to showcase the company’s TerraMax ® Unmanned Ground Vehicle (UGV) technology.
Sign-up for Oshkosh Defense Demonstrates Autonomous Route Clearance Mission Capability at Eurosatory 2014 investment picks
New variant guided successfully to target with laser PARIS , June 15, 2014 /PRNewswire/ -- In a company-funded R&D initiative, Raytheon Company (NYSE: RTN) successfully fired the dual-mode GPS- and laser-guided Excalibur S for the first time.
Sign-up for Raytheon conducts first live fire test of Excalibur S investment picks
Results from Clinical Study in Type 2 Diabetes Patients with Renal Impairment and Preclinical Study in Type 1 Diabetes THE WOODLANDS, Texas , June 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) , presented data at the 74 th Scientific Sessions of the American Diabetes Association (ADA) in San Francisco on LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) that is designed to lower blood glucose levels through two insulin-independent mechanisms of action.
Sign-up for Lexicon Presents LX4211 Data at American Diabetes Association Meeting investment picks
NEW YORK, June 14, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that it has filed a class action lawsuit on behalf of purchasers of Ocean Power Technologies, Inc. (Nasdaq:OPTT) securities during the period from January 14, 2014 to June 9, 2014 inclusive, seeking to recover damages for violations of the federal securities laws.
Sign-up for The Rosen Law Firm Files Securities Fraud Class Action Against Ocean Power Technologies, Inc. -- OPTT investment picks
Data presented at the 74th American Diabetes Association Scientific Sessions® expand body of evidence for the mechanism of action of basal insulin peglispro in healthy human subjects SAN FRANCISCO , June 14, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data regarding the mechanism of action of basal insulin peglispro (BIL). When BIL and insulin glargine were each administered to achieve complete suppression of glucose production, which principally comes from the liver, BIL showed less activity in peripheral tissues, such as muscle and fat, than insulin glargine.
Sign-up for Lilly's Basal Insulin Peglispro Shows Novel Mechanism of Action investment picks
Once-Weekly Dulaglutide 1.5 mg Also Demonstrates Weight Loss, Low Rates of Hypoglycemia in AWARD-6 Trial SAN FRANCISCO , June 14, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today released detailed results from dulaglutide's sixth AWARD trial, showing that once-weekly dulaglutide 1.5 mg was non-inferior to once-daily liraglutide 1.8 mg.
Sign-up for Lilly's Once-Weekly Dulaglutide Shows Similar Reductions in Average Blood Glucose Levels as Once-Daily Liraglutide in Head-to-Head Trial investment picks
Data Presented at ADA Scientific Sessions Suggest DRI May Enable More Timely and Focused Risk Assessment and Intervention in At-risk Patients SAN FRANCISCO , June 14, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX) , a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced the presentation of data demonstrating the utility of the company's NMR-based diabetes risk index (DRI) in identifying normal-weight individuals at high risk of progressing to type 2 diabetes.
Sign-up for NMR-based Diabetes Risk Index (DRI) Helps to Identify Normal-weight Individuals at High Risk of Progressing to Type 2 Diabetes investment picks
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that a retrospective analysis of MM-003, the Company’s phase III study of pomalidomide plus low-dose dexamethasone compared with high-dose dexamethasone in patients with refractory multiple myeloma who have failed therapy with both bortezomib and lenalidomide, administered either alone or in combination, were presented at the 19th European Hematology Association annual congress.
Sign-up for Retrospective Analysis of Overall Survival Adjusting for Patient Crossover in Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Presented at EHA investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Domain.com Partners with Directi at ICANN 50 to Empower Small Businesses Globally to Retrospective Analysis of Overall Survival Adjusting for Patient Crossover in Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Presented at EHA
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices